Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing Investor Syndicate Includes Leading Biotech And Mutual Funds HOUSTON-- --Bellicum Pharmaceuticals, Inc., a biotechnology company focused on developing safer and more effective cellular immunotherapies, today announced the successful completion of a $55M Series C ... (more)
http://ift.tt/1ATXUDc
http://ift.tt/1ATXUDc
No comments:
Post a Comment